Croatia vs Cyprus: Cause of death, by non-communicable diseases, ages 15-59
Croatia
72.8%
in 2021
Cyprus
73.9%
in 2021
Croatia rank
32nd
Cyprus rank
30th
Cause of death, by non-communicable diseases, ages 15-59 over time
- Croatia
- Cyprus
How they compare
Cyprus currently reports 73.9% against 72.8% in Croatia, a difference of 1.1%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Croatia ahead.
Croatia ranks 32nd and Cyprus ranks 30th of 185 countries.
Across the 3 decades both report, Croatia averaged higher in 2 and Cyprus in 1.
Head to head by decade
| Decade | Croatia | Cyprus | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 77.8% | 71.8% | 6.0% | Croatia |
| 2010s | 82.8% | 79.6% | 3.2% | Croatia |
| 2020s | 75.4% | 77.3% | 1.8% | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Croatia or Cyprus?
- Cyprus, at 73.9% against 72.8% in Croatia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Croatia and Cyprus?
- 1.1%, with Cyprus ahead.
- How many years of comparable data are there for Croatia and Cyprus?
- 6 years are reported by both, from 2000 to 2021.
- How do Croatia and Cyprus rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Croatia ranks 32nd and Cyprus ranks 30th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.